Participants must have participated in a prior study with the investigational drug etripamil (the NODE-301, NODE-302, or NODE-303 study). The study is being done to determine the safety of etripamil 70 mg for the treatment of multiple episodes of PSVT in an at-home setting.
Contact phone
Sparrow Clinical Research Institute | 517.364.5760
Contact email
scri@sparrow.org
Principal investigator
Dr. John Ip, MD, FACC
Trial Category
Heart & Vascular
Trial SubCategory
Cardiac Arrhythmia
Webform